| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 25 Aug 2025 | 25 Aug 2025 |
| Qms Medical Allied Services Limited has informed the Exchange regarding Board meeting held on August 25, 2025. | ||
| Board Meeting | 22 Aug 2025 | 19 Aug 2025 |
| To consider Fund Raising Qms Medical Allied Services Limited has informed the Exchange regarding Board meeting held on August 22, 2025. (As Per NSE Announcement Dated on: 22.08.2025) In compliance with Regulation 29(1)(d) and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), we hereby inform you that a meeting of the Board of Directors of QMS Medical Allied Services Limited (the Company) is scheduled to be held on Friday, August 29, 2025, to inter-alia, consider and decide on various matters in connection with aforesaid Rights Issue such as determination of Issue price, Rights Entitlement ratio, Record Date and other terms and conditions with respect to the Rights Issue, subject to the receipt of in-principle approval from the stock exchanges where the securities of the Company are listed or such other regulatory authorities as may be required. (As Per NSE Announcement Dated On : 25.08.2025) | ||
| Board Meeting | 13 Aug 2025 | 7 Aug 2025 |
| To consider other business matters Qms Medical Allied Services Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025. (As Per NSE Announcement Dated On : 13.08.2025) | ||
| Board Meeting | 29 May 2025 | 26 May 2025 |
| To consider and approve the financial results for the period ended March 31, 2025 and dividend Qms Medical Allied Services Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2025, recommended Final Dividend of Rs. 0.5 per equity share. (As per NSE Announcement Dated on 29/05/2025) | ||
| Board Meeting | 14 Feb 2025 | 10 Feb 2025 |
| 1. To consider and approve the Standalone Unaudited Financial Results of the Company along with Limited Review Report for the Quarter year ended December 31, 2024.2. To consider and approve the Consolidated Unaudited Financial Results of the Company along with Limited Review Report for the Quarter ended December 31, 2024 Qms Medical Allied Services Limited has informed the Exchange regarding Board meeting held on February 14, 2025. The Board in its meeting today have considered and approved Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2024 (As Per NSE Announcement Dated on: 14.02.2025) | ||
| Board Meeting | 14 Nov 2024 | 8 Nov 2024 |
| To consider and approve the financial results for the period ended September 30, 2024 Qms Medical Allied Services Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024. (As Per NSE Announcement Dated on: 14/11/2024) | ||
| Board Meeting | 29 Aug 2024 | 26 Aug 2024 |
| To consider Fund Raising and other business matters Qms Medical Allied Services Limited has informed the Exchange regarding Board meeting held on August 29, 2024. (As Per NSE Announcement Dated on: 29/08/2024) Qms Medical Allied Services Limited has informed the Exchange regarding Board meeting held on December 02, 2024. (As Per NSE Announcement Dated on: 02/12/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.